Delivery Order SPE2DB20D2002-SPE2DB24FL71D

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Adderall XR 20 mg capsules. The $1,079.56 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of Adderall XR 10 mg capsules to the Defense Logistics Agency (DLA). The $1,964.73 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of Adderall XR 30 mg capsules. The $1,839.04 firm fixed-price delivery order contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Adderall XR 15 mg capsules. The $1,307.90 firm fixed price delivery order has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,545.81 firm fixed-price delivery order is for the supply of ADDERALL XR 30 MG CAPSULE 100S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) from the Defense Logistics Agency (DLA) is for the delivery of Adderall XR 20 mg capsules. The $3,766.28 firm fixed-price delivery order is a child contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $1,121.18 for the supply of Adderall XR 20 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of Adderall XR 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,154.28, is a firm-fixed price delivery order that does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,031.74 and is a delivery order contract for the supply of Adderall XR 30 mg capsules. The contract has a period of performance ending on January 23, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.14 firm fixed-price delivery order is for the supply of 4,564,660,251 Adderall XR 10 mg capsules. The contract has a completion date of May 21, 2024 and was awarded on May 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL71D
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Adderall XR 30 mg capsules to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order valued at $5,134.39, with a completion date of July 23, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also includes a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not indicate any set-aside requirements, suggesting it was open to full and open competition.

Generated 2/27/25, 10:47 AM